| Literature DB >> 35345397 |
Charles Obinwanne Okoye1,2,3,4, Emmanuel Sunday Okeke3,5,6,4, Kingsley Chukwuebuka Okoye3,7,4, Daniel Echude1,4, Felix Attawal Andong1, Kingsley Ikechukwu Chukwudozie8,4, Henrietta Ukamaka Okoye9, Chigozie Damian Ezeonyejiaku10.
Abstract
The occurrence of emerging contaminants (ECs) such as pharmaceuticals, personal care products (PPCPs) and pesticides in the aquatic environment has raised serious concerns about their adverse effects on aquatic species and humans. Because of their toxicity and bioactive nature, PPCPs and pesticides have more potential to impair water systems than any other contaminants, causing several adverse effects, including antibiotic resistance, reproductive impairment, biomagnification, bioaccumulation, etc. Over 35 publications from Africa have reported on the occurrence and fate of PPCPs and pesticides in African water systems with little or no data on remediation and control. As a result, adequate intervention strategies are needed for regulating the persistence of PPCPs and pesticides in African water systems.Entities:
Keywords: African water systems; Emerging contaminants; Remediation
Year: 2022 PMID: 35345397 PMCID: PMC8956874 DOI: 10.1016/j.heliyon.2022.e09143
Source DB: PubMed Journal: Heliyon ISSN: 2405-8440
Studies on the occurrence and fate of PPCPs and pesticides in various water systems in Africa.
| Region | Occurrence | PPCPs and pesticides type | Concentration ( | Detection | Fate | References |
|---|---|---|---|---|---|---|
| Southern Africa | Surface water | Ibuprofen | 19.2 | HPLC-DAD | Reduces sperm motility and fertilization, influences the hatch rate, motion, locomotion, and gene expression in aquatic organisms | [ |
| Southern Africa | Wastewater | Ibuprofen | 1.38 | HPLC-MS/MS | Incomplete phase separations, resistant to biodegradation | [ |
| West Africa | Surface water/groundwater | Dieldrin | 1.51 | GC-ECD | Bioconcentration and biomagnification via terrestrial and aquatic food chains; increase the water solubility of nonpolar compounds | [ |
| West Africa | Surface water | Dieldrin, endrin, dichlorodiphenyltrichloroethane (DDT), endosulfanaldehyde, and phosphomethylglycine | 0.02–0.15 | GC-ECD | Biomagnification via terrestrial and aquatic food chains | [ |
| North Africa | Ground water, surface water, wastewater | Ibuprofen, naproxen, ketoprofen, diclofenac | 0.1109–6.554 | GC-MS | Higher toxicity of direct discharge of untreated wastewaters, Implicates removal efficiencies of wastewater treatment plants, pseudo-persistence | [ |
| West Africa | Surface water | Trimethoprim, Tetracycline, Acetylsalicylic acid, Betasitosterol, Bezafibrate, Chlortetracycline, Clarithromycin, Clofibric acid, Doxycycline, Estradiol, Estriol, Estrone, Etofibrate, Fenofibrate, Fenoprofen, Ibuprofen, Indometacin, Ketoprofen, Mestranol, Pentoxifylline, Phenacetin, Phenazone, Sulfadiazine, Sulfadimidine | 0.01–8.84 | GC-MS | Biomagnification via terrestrial and aquatic food chains | [ |
| West Africa | Surface water, groundwater | Hydrocortisone, Acetaminophen, Metformin, Gabapentin, Nicotine, Codeine, Sulfamethoxazole, Caffeine, Trimethoprim, Amoxicillin, Tramadol, Metoprolol, Propranolol, Carbamazepine, Erythromycin, DEET, Oxazepam, Mefloquine, Naproxen, Valsartan, Diazepam, Glyburide, Diclofenac, Ibuprofen, Clotrimazole, Meclofenamic acid, Gemfibrozil | 0.003–1.614 | LC-MS/MS | Development of antibiotic-resistant genes in bacterial populations | [ |
| West Africa | Surface water, wastewater | Equilin, Caffeine, Chloramphenicol, Erythromycin, Ciprofloxacin, Roxithromycin, Sulfamethoxazole, Lincomycin, Acetamidophenol/paracetamol/acetaminophen, Carbamazepine, Diclofenac sodium, Oxybenzone, N, N-dimethyl3-methylbenzamide (DEET), Triclosan, Triclocarban, Sulfathiazole, Methylparaben | 0.001–0.47 | LC-MS/MS | Biomagnification via terrestrial and aquatic food chains | [ |
| West Africa | Surface water, seawater | Acetaminophen, Amoxicillin | 0.0058–1.23 | HPLC | Biomagnification via terrestrial and aquatic food chains | [ |
| West Africa | Groundwater | Sulphadoxine, Amodiaquine, Chloroquine | 58–451.6 | HPLC | Persistence and bioaccumulation in the food web | [ |
| West Africa | Surface water | Oxytetracycline | 0.003–0.0048 | HPLC | Creation of antibiotic-resistant strains in natural bacterial populations | [ |
| Southern Africa | Surface water, wastewater | Ciprofloxacin, Aspirin, Ampicillin, Nalidixic acid, Ketoprofen, Bezafibrate, Diclofenac, Ibuprofen, Acetaminophen, Sulfamethoxazole, Atenolol, Caffeine, Streptomycin, Tetracycline, Erythromycin, Chloramphenicol, Tylosin | 0.14–0.97 | HPLC-DAD | Development of antibiotic resistance and feminization or masculinization of aquatic organisms, pseudo-persistence | [ |
| East Africa | Surface water, wastewater | Sulfadoxin, sulfamethoxazole, paracetamol, ibuprofen, sulfamethoxazole, methylparaben, carbamazepine, diclofenac, indomethacin | 100–1000 | UPLC-MS/MS | Persistent, and tend to accumulate, limited biodegradability, easily attached to a particle for transport in water, bioaccumulate in aquatic organisms | [ |
| West Africa | Seawater | Metronidazole, Trimethoprim, Sulphamethoxazole, Ampicillin, Cloxacillin | 0.07–1.599 | HPLC | Development of antibiotic-resistant genes in bacterial populations | [ |
| East Africa | Wastewater | Amoxicillin, ampicillin, and ciprofloxacin | 37–367 | HPLC-UV | Incomplete removal during soil passage due to incomplete sorption | [ |
| North Africa | Surface water | Oxycladine citrate, nepagine, and salbutamol | 0–4.7.0 | Persistent, and tend to accumulate, limited biodegradability, easily attached to a particle for transport in water, bioaccumulate in aquatic organisms | [ | |
| North Africa | Surface water | Amoxicillin, erythromycin, sulfamethoxazole, tetracycline, ciprofloxacin, oxolinic acid, trimethoprim | 0.0019–4.107 | LC–MS/MS | Development of antibiotic-resistant strains in natural bacterial populations | [ |
| Northeastern Africa | Surface water, groundwater | Bisphenol A (BPA), methylparaben, ethylparaben, propylparaben, butylparaben, o-phenylphenol | 0.0064–0.071 | UPLC–MS/MS | Elicits adverse effects in reproductive organs of aquatic organisms, bioaccumulation, and biomagnification in the food web | [ |
| North Africa | Surface water | Acetaminophen, ibuprofen | 0.22–0.9 | HPLC-UV | Development of antibiotic-resistant strains in natural bacterial populations | [ |
| North Africa | Seawater, groundwater | Chloramphenicol, thiamphenicol, florfenicol, paromomycin, dihydrostreptomycin, kanamycin, apramycin, streptomycin, amikacin, sisomicin, neomycin, gentamycin | 3.4–18.4 | UPLC-MS/MS | Persistence of antibiotic-resistant microorganisms | [ |
| North Africa | Groundwater, wastewater | Carbamazepine, carbamazepine epoxide, dihydroxycarbamazepine | 0.0102–0.1145 | HPLC | Highly recalcitrant to standard bioremediation; wastewater leaches into groundwater depending on its sorption potential and on its transformation into the soil | [ |
| Southern Africa | Seawater | Diclofenac, sulfamethoxazole, phenytoin, carbamazepine, lamivudine, caffeine, acetaminophen | 0.010–0.034 | UPLC TQ-MS | Poses an adverse environmental risk to non-targeted organisms via biomagnification in the food chain | [ |
| North Africa | Wastewater | Carbamazepine, naproxen, ibuprofen | 8.02–132 | HPLC-UV | Incomplete phase separations, resistant to biodegradation | [ |
| Southern Africa | Surface water, wastewater | Ibuprofen, ketoprofen, diclofenac, naproxen, triclocarban, triclosan, codeine, tramadol, atenolol, chloramphenicol, ciprofloxacin, clarithromycin, tetracycline, acetaminophen, norfloxacin, ofloxacin, sulfamethoxazole, sulfasalazine, azithromycin, trimethoprim, caffeine, dextromethorphan, mephedrone, methamphetamine, cocaine, carbamazepin, cotinine, nicotine, alkylphenol, ethoxylates, fluoxetine, fexofenadine | 0.0276–0.4502 | UPLC/TQD-MS | Back-transformation of contaminants, recurring negative mass balances, decreases efficiency, capacity, and selectivity of contaminant sorption | [ |
| Southern Africa | Wastewater | Naproxen and ibuprofen, triclosan | 10.7–127.7 | HPLC-UV | Renders traditional sampling approaches insufficient | [ |
| Southern Africa | Surface water, wastewater | Ciprofoxacin, ofoxacin, norfoxacin, tetracycline, atenolol, triclosan, triclocarban, diclofenac, acetaminophen, ibuprofen, ketoprofen | 0.3–119 | LC- TQ-MS | Low removal rate impedes the growth and survival of aquatic organisms in receiving water bodies | [ |
| North Africa | Groundwater, wastewater, surface water, | Atenolol, benzafibrate, 1-H-benzotriazole, bisphenol A, caffeine, carbamazepine, diclophenac, ethylparabene, fenofibric acid, furosemide, gemfibrozil, ibuprofene, ibuprofene, ibuprofene, ketoprofene, methlyparabene, metoprolol, naproxen, nonylphenol, o-desmethyl-naproxene, oxazepam, paracetamol, propylparabene, sulfamethoxazole, tolyltriazoles, triclocarban, triclosan, trimethoprim, antibiotic | <0.289 | HPLC, UPLC/MS-MS | Incomplete removal during soil passage due to incomplete sorption and/or biodegradation, high oxygen demand, photodegradation of leads to harmful disposal in surface waters | [ |
| Southern Africa | Surface water, wastewater | Efavirenz, emtricitabine, lamivudine, nevirapine, ritonavir, zidovudine, 8,14-dihydroxyEfavirenz, 12-hydroxy-Nevirapine, desthiazolylmethyloxycarbonyl ritonavir, Nevirapine-D | <0.172 | LC-MS/MS | Significant losses of polar targets in WWTPs due to low solubility and partial removal, eventual seepage to surface water and groundwater | [ |
| East Africa | Surface water | Sulfamethoxazole, trimethoprim, ciprofloxacin, lamivudine, nevirapine, zidovudine | 0.509–13.8 | LC-ESI-MS/MS | Development of antimicrobial resistance and possible toxicity to sensitive organisms | [ |
| Southern Africa | Groundwater | Atrazine, carbamazepine, cinchonidine, cinchonine, diphenylamine, enilconazole, ephedrin, flecainide, fluconazole, hexazinone, imidacloprid, metazachlor, metolachlor, minoxidil, nalidixicacid, paracetamol, phenytoin, sebuthylazine-desethyl, simazine, sulphisomidine, tebuthiuron, telmisartan, temazepam, terbumeton, terbuthylazine, thiabendazole | <0.35 | LC-MS/MS | Low sperm volume and motility, fetal growth defects, increase in DNA damage, congenital anomalies, and cardiovascular | [ |
| Southern Africa | Wastewater | Efavirenz, nevirapine | 5.5–14.0 | GC-MS | De-conjugation of metabolites in the WWTP, resistance to degradation, lack of binding of the metabolites to the sludge | [ |
| Southern Africa | Surface water, wastewater | Zalcitabine, tenofovir, abacavir, efavirenz, lamivudine, didanosine, stavudine, zidovudine, nevirapine, indinavir, ritonavir, lopinavir, caffeine | 0.0265–0.43 | LC-MS/MS, UHPLC-MS/MS | Resistant to degradation, ubiquitous occurrence to surface water, promotes the development of drug resistance in other pathogens | [ |
| Southern Africa | Surface water | Efavirenz, nevirapine, carbamazepine | 0.164–0.593 | LC-MS/MS | Induces antibacterial resistance, neurobehavioral disorders in aquatic animals, diminished predator evasive behavior, less aggressive nest defense | [ |
| Southern Africa | Wastewater, groundwater | Penciclovir, famciclovir, ribavirin, paracetamol, ketoprofen, diclofenac, fenoprofen, ibuprofen, carbamazepine, primidone, sulfamethoxazole, pindolol | <0.0196 | HPLC- CAD | Inefficient removal in WWTPs, distribution by aqueous transport, food-chain dispersal, mineralization to carbon dioxide and water, adsorption on suspended solids | [ |
CAD-charged aerosol detector; TQ-MS- triple quadrupole mass spectrometer; GC-ECD-gas chromatography – electron capture detector; LC/MS/MS- liquid chromatography-tandem mass spectrometry; HPLC- high-performance liquid chromatography; UHPLC/MS/MS- ultra high-performance liquid chromatography-tandem mass spectrometry; UPLC- ultra performance liquid chromatography; ESI- electrospray ionization.
Figure 1Sources, transport, and exposure routes of PPCPs and pesticides in various water systems. Contamination from specific point sources is due to direct disposal and untreated releases from domestic, commercial, industrial leakages, spills on farmyards, and wastewater treatment plant effluents. Source: authors.